Felodipine extended_release tablet vs nitrendipine tablet in treating hypertension
Jiang Zhen
Abstract
Jiang Zhen
Abstract
AIM: To compare the effects of felodipine extended_release(ER) with nitrendipine on hypertensive disease. METHODS: Among 162 mild to moderate hypertensive patients, 98 patients (M 67, F 31, age 51 a±s 6 a) received felodipine_ER 5_10 mg, po, qd for 4 wk; 64 patients (M 47, F 17, age 50 a±8 a) received nitrendipine 10 mg, po, bid or tid for 4 wk. RESULTS: The clinical total effective rate of felodipine_ER group was higher than that of nitrendipine group (95% vs 81%, P0.01). Adverse effects of felodipine_ER group were fewer than those of nitrendipine group (15% vs 20%, P0.05). CONCLUSION: Felodipine_ER is a safe and effective drug on hypertensive disease, and superior to nitrendipine. 1The People's Hospital of Jimo City, Jimo SHANDONG 266200
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM: To compare the effects of felodipine extended_release(ER) with nitrendipine on hypertensive disease. METHODS: Among 162 mild to moderate hypertensive patients, 98 patients (M 67, F 31, age 51 a±s 6 a) received felodipine_ER 5_10 mg, po, qd for 4 wk; 64 patients (M 47, F 17, age 50 a±8 a) received nitrendipine 10 mg, po, bid or tid for 4 wk. RESULTS: The clinical total effective rate of felodipine_ER group was higher than that of nitrendipine group (95% vs 81%, P0.01). Adverse effects of felodipine_ER group were fewer than those of nitrendipine group (15% vs 20%, P0.05). CONCLUSION: Felodipine_ER is a safe and effective drug on hypertensive disease, and superior to nitrendipine. 1The People's Hospital of Jimo City, Jimo SHANDONG 266200
Key concepts: Nitrendipine, Felodipine, Medicine, Hypertensive disease, Adverse effect, Pharmacology, Anesthesia, Internal medicine